Strategic Acquisition Aluna was acquired by Huma Therapeutics in May 2025, signaling potential consolidation moves and opportunities to engage with a larger healthcare ecosystem and partners involved in respiratory care.

Respiratory Focus As a chronic lung health management platform combining a spirometer, mobile app, and ML insights, Aluna presents cross-sell and integration opportunities with clinics, allergists, pulmonologists, and insurers looking to augment asthma management programs.

Partnered Ecosystem Existing partnerships and integrations with EHR providers and practice management solutions, plus a history of investor-backed growth, indicate receptivity to enterprise partnerships, channel partners, and co-marketing arrangements.

Scaling Potential Funding history shows Series B support and revenue in the low millions, suggesting capacity for aggressive sales motions targeting mid-market to enterprise healthcare providers and specialty clinics expanding remote patient monitoring.

Data and Tech Fit Tech stack and data-driven approach (ML, spirometry data, and integrations with DBs and CRM tools) align with customers seeking interoperable, analytics-led respiratory health solutions and scalable, secure patient data workflows.